GMP Production

The InnovaVector GMP facility (~500 m2), located in Pozzuoli (Napoli, Italy), is under construction.

Quality-by-Design and Risk Management are applied to the design, construction, qualification and validation of the facility.

Classified plant designed to accommodate cell room, up/down stream suites, aseptic filling area and quality control with quality management system in place.

The objective is to get the GMP facility authorized by the Italian Drug Agency (AIFA) by the end of 2022 for the manufacturing and release of AAV batches for phaseI/II clinical studies.